A recent study described a remarkable effect of the adaptive transfer of neoantigen-specific T cells in hormone-receptor-positive metastatic breast cancer patients [47], whereas another study has demonstrated that neoantigens induce anti-tumor immunity in xenograft models [48]. Here, NR4A1 is linked to neoplasm.